Cytosorb® hemoadsorption of apixaban during emergent cardio-pulmonary bypass: a case report
Authors:
- 26 October 2020
- journal article
- case report
- Published by SAGE Publications in Perfusion
- Vol. 36 (8) , 873-875
Abstract
Background: Peri-operative coagulation management of patients receiving apixaban, a new oral anticoagulant, is difficult. The CytoSorb® hemoadsorption device might represent a therapeutic option to reduce apixaban’s pharmacological and inflammatory effects during high-risk surgery. Case presentation: An 83-year-old woman treated with Apixaban underwent emergent redo mitral valve replacement for prosthetic valve endocarditis. A CytoSorb® cartridge was added to the cardio-pulmonary bypass (CPB) circuit. Apixaban-specific anti-factor Xa activity (AFXaA) were measured peri-operatively. After 100 minutes of CPB, a 50% AFXaA rate decrease was observed as compared to pre-CPB values. Furthermore, we noticed 39% and 44% reductions of AFXaA levels in comparison to the expected levels in patients with normal or altered renal function, respectively. Conclusion: Insertion of a CytoSorb® cartridge in the CPB was safe and associated with rapid correction of Apixaban-associated anticoagulation.Keywords
This publication has 10 references indexed in Scilit:
- Cytosorb Adsorption During Emergency Cardiac Operations in Patients at High Risk of BleedingThe Annals of Thoracic Surgery, 2019
- Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic ReviewClinical Pharmacokinetics, 2019
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsNew England Journal of Medicine, 2019
- Hemoadsorption with CytoSorb®Intensive Care Medicine, 2018
- In vitro comparison of the adsorption of inflammatory mediators by blood purification devicesIntensive Care Medicine Experimental, 2018
- Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation—an observational studyClinical Transplantation, 2018
- Treatment of Post-Cardiopulmonary Bypass SIRS by Hemoadsorption: A Case SeriesThe International Journal of Artificial Organs, 2016
- Infective endocarditisThe Lancet, 2016
- Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixabanThe Journal of Clinical Pharmacology, 2015
- Systemic inflammatory response syndrome after cardiac operationsThe Annals of Thoracic Surgery, 1996